✨ Medicines Notices




NEW ZEALAND GAZETTE, No. 52

13 MAY 2004

Provisional Consent to the Distribution of New Medicines

Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Benztrop

Active Ingredient:
Benzatropine mesilate 2mg

Dosage Form:
Tablet

New Zealand Sponsor:
AFT Pharmaceuticals Limited

Manufacturer:
Pharmascience Inc, Montreal, Quebec, Canada

Note: This consent is valid for two years from the date of publication of this notice.

Product:
Luveris

Active Ingredient:
Lutropin alfa, rch 75IU

Dosage Form:
Powder for injection

New Zealand Sponsor:
Douglas Pharmaceuticals Limited

Manufacturer:
Laboratories Serono SA, Aubonne, Switzerland

Note: This consent is valid for two years from the date of publication of this notice.

Dated this 2nd day of May 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2963

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product:
Blink Revitalising Eye Drops

Active Ingredients:
Hypromellose 1.5mg/mL
Trometamol 12mg/mL
Tyloxapol 0.25mg/mL

Dosage Form:
Contact lens solution

New Zealand Sponsor:
Advanced Medical Optics Australia Pty Limited

Manufacturer:
Allergan Pharmaceuticals Ireland, Westport, County Mayo, Eire

Product:
Myfortic

Active Ingredient:
Mycophenolate sodium 192.4mg equivalent to mycophenolic acid 180mg

Dosage Form:
Enteric coated tablet

New Zealand Sponsor:
Novartis New Zealand Limited

Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Myfortic

Active Ingredient:
Mycophenolate sodium 384.8mg equivalent to mycophenolic acid 360mg

Dosage Form:
Enteric coated tablet

New Zealand Sponsor:
Novartis New Zealand Limited

Manufacturer:
Novartis Pharma Stein AG, Stein, Switzerland

Product:
Obix

Active Ingredient:
Orlistat 120mg

Dosage Form:
Capsule

New Zealand Sponsor:
Roche Products (New Zealand) Limited

Manufacturers:
F Hoffmann-La Roche Ltd, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Prodotti SpA, Segrate, Milan, Italy

Dated this 2nd day of May 2004.

DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the 6th day of July 2001).

go2964

Revocation of Prohibition From Prescribing Medicines

Pursuant to section 48 (3) of the Medicines Act 1981,
I, Annette King, Minister of Health, hereby revoke the notice issued on 26 May 1993 and published in
the New Zealand Gazette, 10 June 1993, page 1515, that prohibits

Dr Saba La Hood, medical practitioner of Wellington

from prescribing benzodiazepines and their derivatives.

Dated at Wellington this 4th day of May 2004.

ANNETTE KING, Minister of Health.

go3048



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2004, No 52


Gazette.govt.nz PDF NZ Gazette 2004, No 52





✨ LLM interpretation of page content

πŸ₯ Provisional Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
2 May 2004
Medicines, Provisional Consent, Benztrop, Luveris, Benzatropine mesilate, Lutropin alfa
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Consent to Distribution of New Medicines

πŸ₯ Health & Social Welfare
2 May 2004
Medicines, Consent, Blink Revitalising Eye Drops, Myfortic, Obix, Hypromellose, Mycophenolate sodium, Orlistat
  • DON MATHESON, Deputy Director-General, Public Health

πŸ₯ Revocation of Prohibition From Prescribing Medicines

πŸ₯ Health & Social Welfare
4 May 2004
Medicines, Revocation, Prohibition, Benzodiazepines, Medical Practitioner
  • Saba La Hood (Dr), Revoked prohibition from prescribing benzodiazepines

  • ANNETTE KING, Minister of Health